CAS 406477-46-1 Fusionglycoprotein(92-106)

Send Inquiry
CAS 406477-46-1 Fusionglycoprotein(92-106)
Details
Viral fusion glycoprotein residues 92-106;
Category: Viral envelope epitope / vaccine-research peptide.
Peptide Purity (HPLC) ≥95%
CAS No. 406477-46-1
Structure Linear 15-mer (viral fusion glycoprotein 92-106)
Solubility Water, DMSO cosolvent, PBS
Storage Powder, −20°C, dry, light-protected
Category
Epitope Peptides
Share to
Description

Shanghai Sonyt Biotechnology Co., Ltd. is one of the leading manufacturers and suppliers of cas 406477-46-1 fusionglycoprotein(92-106) in China, also supports custom service. Welcome to wholesale bulk high quality cas 406477-46-1 fusionglycoprotein(92-106) from our factory. Contact us for more details.

 

Description RSV fusion (F) glycoprotein residues 92–106 containing a T-cell epitope; RSV-F is the core vaccine/neutralizing-antigen target.

 

Product Basic Information Table

 

Product Standard English Name Product Abbreviation / Alias Function Tags (comma-separated) Core Structure Molecular Formula Exact Mass (Da) Average MW (Da) Salt Form Length (aa)
Fusion glycoprotein (92-106) Peptide (RSV F protein) Fusion glycoprotein (92-106); ELQLLMQSTPPTNNR; RSV F protein P8:F92-106 epitope; H-2Kd-restricted CTL epitope Respiratory syncytial virus,RSV fusion protein,CTL epitope,H-2Kd-restricted,motif-negative epitope,vaccine research,neutralization antigen target,CD8+ T cells H-Glu-Leu-Gln-Leu-Leu-Met-Gln-Ser-Thr-Pro-Pro-Thr-Asn-Asn-Arg-OH; 15-mer from residues 92-106 of the human respiratory syncytial virus (HRSV) subtype A (A2 reference strain) fusion glycoprotein F (within the F2 subunit, near the N-terminus after the signal peptide), i.e., the literature P8:F92-106 epitope; linear peptide; contains Met (oxidation-prone) C73H124N22O25S 1740.88 1741.98 Typically TFA salt (residual TFA from HPLC purification; per supplier COA) 15

 

Physicochemical Solubility & Storage Parameters

 

Product Code Appearance Long-term Storage Short-term Storage Solution Stability Solid Powder Stability
PEP-RSVF-01 White to off-white powder Store at -20°C, dry, sealed and protected from light (Met-containing, nitrogen purge recommended) Short-term storage at 2-8°C, light-protected and dry; use within 2-4 weeks Moderately hydrophobic (L×3/M): first dissolve in a small amount of DMSO, then dilute with water/PBS; Met-containing - deoxygenate reconstituted solution, prepare fresh, avoid repeated freeze-thaw powder stable at -20°C when dry, sealed and light-protected (supplier: ~3 years as powder, ~6 months in solution); weigh quickly after opening and refreeze

 

Functional Description

 

Product Code Frontend Short Summary Detailed Biological Function Description Applicable Research Areas (comma-separated) Targets / Pathways
PEP-RSVF-01 The 15-mer ELQLLMQSTPPTNNR from human RSV A2 fusion glycoprotein residues 92-106 (P8:F92-106), the first murine H-2Kd-restricted CD8+ CTL epitope identified in the RSV F protein (a motif-negative 15-mer), used for RSV vaccine-epitope and antiviral CTL studies. Source: 15-mer spanning residues 92-106 of the human respiratory syncytial virus (HRSV) subtype A (A2 reference strain) fusion glycoprotein F (F2 subunit, near the N-terminus after the signal peptide). Epitope property: the literature P8:F92-106 (Jiang et al., J Gen Virol 2002;83:429-438), the first murine CD8+ CTL epitope identified in the RSV F protein, H-2Kd (MHC class I)-restricted (BALB/c mice); this 15-mer is a "motif-negative" epitope - all 15 amino acids are required for effective CTL recognition rather than a typical 8-10-mer. Biological significance: in in-vitro MHC-I refolding experiments the peptide forms complexes with H-2Kd heavy chains and beta2-microglobulin; immunization of BALB/c mice induces peptide- and RSV-specific CTLs and significantly reduces lung viral load after challenge, with protective effects also conferred by adoptive transfer of CD8+ T cells. Applications: RSV vaccine-epitope design and immunogen evaluation, antiviral CTL-response studies, non-canonical (motif-negative) MHC-I epitope presentation mechanisms, RSV challenge protection models. Viral immunology,RSV vaccines,CTL epitopes,antiviral immunity,mouse challenge models,epitope presentation mechanisms H-2Kd (MHC class I) / CD8+ T-cell TCR; RSV fusion glycoprotein (strain A2)

 

 

 

 

Hot Tags: cas 406477-46-1 fusionglycoprotein(92-106), China cas 406477-46-1 fusionglycoprotein(92-106) manufacturers, suppliers, factory, cateninpeptide, BCMA72-80, CAS 124454 83 7, CAS 199727 68 9, CAS 265669 37 2, Nucleoprotein 118 126

Send Inquiry